During an inspection conducted on May 31, 2024, the Food and Drug Administration (FDA) issued four citations to Naturavit, Inc., located in Miami, related to food composition, standards, labeling, and economic concerns, according to data posted on the FDA’s website.
The FDA website indicates that the citations were delivered to the company as follows:
- ‘You did not establish product specifications for the identity, purity, strength and composition of the finished dietary supplement.’
- ‘You did not conduct appropriate tests or examinations or rely on a certificate of analysis to determine whether components met established specifications.’
- ‘You did not follow written procedures for quality control operations.’
- ‘You did not follow written procedures for labeling operations.’
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
